Sign In
Free Newsletter
Arizona’s pro-business climate is magnet for clean energy investment, but won’t last without skilled workers
Arizona has a strong track record of attracting new business investment and job creation across a host of economic sectors, including aerospace, bioscience, financial services and technology. But this will only last if Arizona can maintain the skilled workforce needed to translate investment dollars into actual working businesses.
Computer scientist’s path to beating cancer spawned a data-driven treatment approach
Marty Tenenbaum was working as a computer scientist and Internet entrepreneur in northern California in 1998 when he was diagnosed with metastatic melanoma, a type of malignant skin cancer that often spreads to other parts of the body.
Clinical trials take center stage during 2015 AZBio Expo
Medical and science professionals from around the country gathered at the Sheraton Downtown Phoenix April 29 to discuss the role clinical trials play in advancing the bioscience industry.
Rapid growth in bioscience industry in peril
From 2002 to 2011, Arizona bioscience sector played a major role in boosting the state’s economic development. Jobs increased by 45 percent, adding more than 30,700 to the market and sweeping the new industry into Arizona like a wave.
Advances outpace investors: Insiders say in-state bioindustry investment is lagging
Bharath Takulapalli is co-founder and CEO of INanoBio in Tempe. His company is completing a prototype for a fourth-generation genome sequencing machine that would make genome diagnostics faster, easier and much less expensive, so that more doctors and patients could benefit from earlier diagnosis of disease.
Biosensors and the need for early disease detection
The American Cancer Society predicts that in 2014, more than 1.6 million new cases of cancer will arise in the United States and more than half a million people will die from the disease, with 11,400 of those deaths occurring in Arizona. The treatment challenge remains in detecting the disease early enough to have a chance in successfully combating it.
TGen-led study discovers genetic cause of rare ovarian cancer
An international research team led by the Translational Genomics Research Institute (TGen) recently found the cause of a rare type of ovarian cancer that most often strikes girls and young women.
TGen translates genetic research into patient care
Caring for one child with a rare and unknown medical disorder is a challenge for parents and doctors. But when three additional children in the same family are found to have related health problems, all involved are faced with a medical quandary for which some answers have only recently been found through genetic research.
Bioscience roadmap: Investigating a decade-long plan to make Arizona an industry player
The dry, sunny climate of Arizona has always been a draw for people seeking its health benefits. Since 2002, the Flinn Foundation has focused on growing Arizona’s image from one recognized for the therapeutic value of its climate to one known for the therapeutic innovations — and commercial viability — of its bioscience sector.
